What is new in the treatment of interstitial lung diseases

What is new in the treatment of interstitial lung diseases

Interstitial lung diseases (ILDs) comprise an heterogenous group of more than 200 pulmonary disorders characterized by lung architectural distortion, with variable amount of fibrotic and/or inflammatory lesions, and associated with significant morbidity and mortality. Pharmacological management is d...

Full description

Bibliographic Details
Main Authors: Vasilina Sotiropoulou, Thodoris Karampitsakos, Matthaios Katsaras, Ourania Papaioannou, Panagiota Tsiri, Fotios Sampsonas, Argyrios Tzouvelekis
Format: Article
Language:English
Published: European Publishing 2023-06-01
Series:Pneumon
Subjects:
interstitial lung disease
progressive pulmonary fibrosis
nintedanib
pirfenidone
hypersensitivity pneumonitis
connective tissue disease-ilds
Online Access:http://www.pneumon.org/What-is-new-in-the-treatment-of-interstitial-lung-ndiseases,161867,0,2.html

Internet

http://www.pneumon.org/What-is-new-in-the-treatment-of-interstitial-lung-ndiseases,161867,0,2.html

Similar Items